Skip to Main Content

Advertisement

Skip Nav Destination

Mogamulizumab May Be Effective in Relapsed/Refractory T-Cell Leukemia

December 30, 2021
On location

Adrienne A. Phillips, MD, MPH, shares results seen with mogamulizumab in the largest randomized clinical trial of relapsed/refractory T-cell leukemia to date.

Advertisement

Connect with us:

CURRENT ISSUE
August 2022

Advertisement

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement